(Q40484511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Future therapies in the management of critically ill AIDS patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

0 references

Torres RA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Franke-Ruta G

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Barr MR

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

language of work or name

1 reference

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

published in

Critical Care Clinics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

153-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

1 reference

7 January 2021

The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Fluconazole Treatment of Persistent Cryptococcus neoformans Prostatic Infection in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

A pilot study of low-dose zidovudine in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Treatment of toxoplasmic encephalitis with intravenous clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Phase II trial: an evaluation of oral saperconazole in acute vaginal candidosis: a comparison of three dosage schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole againstAspergillus species

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Treatment of invasive aspergillosis with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Itraconazole in the Treatment of Coccidioidomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Intravascular and pleural involvement by Pneumocystis carinii in a patient with the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Evaluation of the Effect of Drugs on the Cyst Form of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Spontaneous pneumothorax with Pneumocystis carinii infection. Occurrence in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Inst

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Acute Respiratory Failure Secondary to Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Aerosolized pentamidine as second line therapy in patients with AIDS and Pneumocystis carinii pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Spontaneous pneumothorax in patients with acquired immunodeficiency syndrome treated with prophylactic aerosolized pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Bacterial pneumonia in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Extrapulmonary Pneumocystosis: The First 50 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Activity of Azithromycin against Cryptosporidia in Immunosuppressed Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Amphotericin B nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

INFLUENCE OF ZIDOVUDINE ON PROGRESSION TO AIDS IN COHORT STUDIES

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

High-dose itraconazole in the treatment of severe mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Strain- and Donor-Related Differences in the Interaction of Mycobacterium avium with Human Monocytes and its Modulation by Interferon-

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Clindamycin with primaquine for Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Resolution of microsporidial epithelial keratopathy in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930214-8

7 January 2021

10.1016/S0749-0704(18)30214-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678542%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference